Current strategies in cationic liposomal vaccine development for anti-cancer therapy
Abstract
Nanomedicine is currently at the forefront of technology. Nanovaccines are a relevant development derived from this field and comprise nanoparticles ranging from 50-250 nm to deliver antigens and other immunomodulatory agents. Their formulation can include liposomes, which are widely known as safe and allow their engineering to be cationic, conferring a superior immunostimulatory effect. This promising strategy for vaccine delivery has gained interest in cancer as it provides higher targeting efficiency, increased antigen stability, prolonged circulation time, and enhanced uptake by antigen-presenting cells, mainly dendritic cells. Therefore, this minireview discusses recent research on cationic liposome-based vaccine delivery systems for anti-cancer therapy. Pubmed, Science Direct, and Google Scholar were screened for original and review papers published in the last ten years. The antigen association with the cationic nanoparticles either by electrostatic interactions or complementary coiled coil peptide pair strategy were found as the most promising strategies. The work also highlights the potential of this therapeutic platform for enhancing the T-cell immune response against cancer through mRNA-containing formulations for different routes of administration, providing a detailed physicochemical characterization of the reported nanosystems.
Copyright (c) 2023 Luis Castillo-Henríquez, Zacarías Pereira-Vega, Mohammad Rizki Fadhil Pratama, José Vega Baudrit
This work is licensed under a Creative Commons Attribution 4.0 International License.
COPYRIGHT AND LICENSE STATEMENT
COPYRIGHT
Biogenesis: Jurnal Ilmiah Biologi is published under the terms of the Creative Commons Attribution license. Authors hold the copyright and retain publishing rights without restriction to their work. Users may read, download, copy, distribute, and print the work in any medium, provided the original work is properly cited.
LICENSE TO PUBLISH
1. License
The use of the article will be governed by the Creative Commons Attribution license as currently displayed on http://creativecommons.org/licenses/by/4.0.
2. Author’s Warranties
The author warrants that the article is original, written by stated author/s, has not been published before, contains no unlawful statements, does not infringe the rights of others, is subject to copyright that is vested exclusively in the author and free of any third party rights, and that any necessary written permissions to quote from other sources have been obtained by the author(s).
3. User Rights
Under the Creative Commons Attribution license, the users are free to download, reuse, reprint, modify, distribute and/or copy the content for any purpose, even commercially, as long as the original authors and source are cited. No permission is required from the authors or the publishers.
4. Co-Authorship
If the article was prepared jointly with other authors, the corresponding author warrants that he/she has been authorized by all co-authors, and agrees to inform his/her co-authors of the terms of this statement.
5. Miscellaneous
Biogenesis: Jurnal Ilmiah Biologi may conform the article to a style of punctuation, spelling, capitalization, and usage that it deems appropriate. The author acknowledges that the article may be published so that it will be publicly accessible and such access will be free of charge for the readers.
